CN105213888A - 一种除湿排毒减肥的夏枯草口服液及其制备方法 - Google Patents
一种除湿排毒减肥的夏枯草口服液及其制备方法 Download PDFInfo
- Publication number
- CN105213888A CN105213888A CN201510756003.2A CN201510756003A CN105213888A CN 105213888 A CN105213888 A CN 105213888A CN 201510756003 A CN201510756003 A CN 201510756003A CN 105213888 A CN105213888 A CN 105213888A
- Authority
- CN
- China
- Prior art keywords
- parts
- spica prunellae
- heat
- oral liquid
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 52
- 239000003053 toxin Substances 0.000 title claims abstract description 22
- 231100000765 toxin Toxicity 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000003814 drug Substances 0.000 claims abstract description 86
- 210000000582 semen Anatomy 0.000 claims abstract description 47
- 229940079593 drug Drugs 0.000 claims abstract description 38
- 239000010231 banlangen Substances 0.000 claims abstract description 16
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 114
- 239000000843 powder Substances 0.000 claims description 30
- 239000000706 filtrate Substances 0.000 claims description 21
- 230000008901 benefit Effects 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 16
- 235000013399 edible fruits Nutrition 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 229910000831 Steel Inorganic materials 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 8
- 238000011068 loading method Methods 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 239000010959 steel Substances 0.000 claims description 8
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 4
- 235000011613 Pinus brutia Nutrition 0.000 claims description 4
- 241000018646 Pinus brutia Species 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 24
- 208000004880 Polyuria Diseases 0.000 abstract description 23
- 230000035619 diuresis Effects 0.000 abstract description 23
- 239000000203 mixture Substances 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 230000005855 radiation Effects 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 description 54
- 210000004185 liver Anatomy 0.000 description 52
- 239000008280 blood Substances 0.000 description 50
- 210000004369 blood Anatomy 0.000 description 49
- 230000000694 effects Effects 0.000 description 47
- 235000019197 fats Nutrition 0.000 description 38
- 238000011282 treatment Methods 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 206010062717 Increased upper airway secretion Diseases 0.000 description 28
- 208000026435 phlegm Diseases 0.000 description 28
- 210000002784 stomach Anatomy 0.000 description 26
- 208000002193 Pain Diseases 0.000 description 25
- 230000036407 pain Effects 0.000 description 25
- 239000000243 solution Substances 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 206010012735 Diarrhoea Diseases 0.000 description 17
- 230000008673 vomiting Effects 0.000 description 16
- 206010011224 Cough Diseases 0.000 description 15
- 206010047700 Vomiting Diseases 0.000 description 15
- 230000008961 swelling Effects 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 206010030113 Oedema Diseases 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 206010023126 Jaundice Diseases 0.000 description 12
- 210000000941 bile Anatomy 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 230000001105 regulatory effect Effects 0.000 description 12
- 208000006820 Arthralgia Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 239000006071 cream Substances 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 208000001848 dysentery Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 11
- 206010017553 Furuncle Diseases 0.000 description 10
- 235000019658 bitter taste Nutrition 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 10
- 210000002700 urine Anatomy 0.000 description 10
- 241000628997 Flos Species 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000014759 maintenance of location Effects 0.000 description 9
- 230000001047 pyretic effect Effects 0.000 description 9
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 8
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 8
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 210000001508 eye Anatomy 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 210000000232 gallbladder Anatomy 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 201000007227 lymph node tuberculosis Diseases 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 229940096998 ursolic acid Drugs 0.000 description 8
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 8
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 7
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 7
- 206010043458 Thirst Diseases 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 7
- 230000036528 appetite Effects 0.000 description 7
- 235000019789 appetite Nutrition 0.000 description 7
- 230000007937 eating Effects 0.000 description 7
- 230000001077 hypotensive effect Effects 0.000 description 7
- 229940100243 oleanolic acid Drugs 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 7
- 235000021251 pulses Nutrition 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 230000035807 sensation Effects 0.000 description 7
- 235000019615 sensations Nutrition 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 6
- 208000004930 Fatty Liver Diseases 0.000 description 6
- 206010019708 Hepatic steatosis Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 208000010706 fatty liver disease Diseases 0.000 description 6
- 208000006750 hematuria Diseases 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 210000004706 scrotum Anatomy 0.000 description 6
- 231100000240 steatosis hepatitis Toxicity 0.000 description 6
- 230000004206 stomach function Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 210000003932 urinary bladder Anatomy 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-fenchone Chemical compound C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 5
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 5
- 108010082126 Alanine transaminase Proteins 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 5
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 5
- 206010041349 Somnolence Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 229940074360 caffeic acid Drugs 0.000 description 5
- 235000004883 caffeic acid Nutrition 0.000 description 5
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 5
- 239000002934 diuretic Substances 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 206010013781 dry mouth Diseases 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 201000003453 lung abscess Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 5
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 5
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 5
- 229960004555 rutoside Drugs 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 4
- 241000555712 Forsythia Species 0.000 description 4
- 206010018498 Goitre Diseases 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 206010030302 Oliguria Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000005946 Xerostomia Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 201000003872 goiter Diseases 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 4
- 229960001661 ursodiol Drugs 0.000 description 4
- 229930006731 (1S,4R)-fenchone Natural products 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 3
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 3
- 208000032139 Halitosis Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 208000002352 blister Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000007336 cyanidin Nutrition 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 235000007242 delphinidin Nutrition 0.000 description 3
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 210000001198 duodenum Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 230000002443 hepatoprotective effect Effects 0.000 description 3
- 230000037315 hyperhidrosis Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000021147 sweet food Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 239000008812 xiaoyanlidan Substances 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000020154 Acnes Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 241000334154 Isatis tinctoria Species 0.000 description 2
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000195474 Sargassum Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 206010048245 Yellow skin Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000010238 camphora Substances 0.000 description 2
- 229940025250 camphora Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 2
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 229930006735 fenchone Natural products 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000008838 gegenqinlian Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000002887 oleanolic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000020825 overweight Nutrition 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000009806 pulsatillae Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 229960005137 succinic acid Drugs 0.000 description 2
- 235000011044 succinic acid Nutrition 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- 229930182493 triterpene saponin Natural products 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000009557 Bak Foong Pill Substances 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 244000036905 Benincasa cerifera Species 0.000 description 1
- 235000011274 Benincasa cerifera Nutrition 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000005373 Dyshidrotic Eczema Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241001215120 Leptospirales Species 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- VUGRLRAUZWGZJP-UHFFFAOYSA-N Plantaginin Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 VUGRLRAUZWGZJP-UHFFFAOYSA-N 0.000 description 1
- SNFFBROYEDWRGB-SASFBZJPSA-N Plantagoside Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1c(O)c(O)cc([C@H]2Oc3c(c(O)cc(O)c3)C(=O)C2)c1 SNFFBROYEDWRGB-SASFBZJPSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- -1 amaroid Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000013245 carbon tetrachloride model Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- HVHKMUMXERBUAN-IFADSCNNSA-N mesobilirubin IXalpha Chemical compound N1C(=O)C(CC)=C(C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C)C(=O)N\3)CC)N2)CCC(O)=O)N1 HVHKMUMXERBUAN-IFADSCNNSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- VUGRLRAUZWGZJP-IAAKTDFRSA-N plantaginin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 VUGRLRAUZWGZJP-IAAKTDFRSA-N 0.000 description 1
- SNFFBROYEDWRGB-NHXQFOETSA-N plantagoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC([C@H]2OC3=CC(O)=CC(O)=C3C(=O)C2)=CC(O)=C1O SNFFBROYEDWRGB-NHXQFOETSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 201000011414 pompholyx Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical group N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种除湿排毒减肥的夏枯草口服液,包括以下重量份数的原料药:夏枯草10~50份,连翘10~20份,佛手10~20份,冬瓜皮10~20份,板蓝根10~20份,车前子10~20份,陈皮10~20份,薏仁10~20份,芦根10~20份,白茅根10~20份,天花粉10~20份,小米草10~20份,白术10~20份,黄芩10~20份,泽泻10~20份,白花蛇舌草10~20份,淫羊藿10~20份,鸡血藤10~20份,荷叶10~20份。本发明选取清火除湿的中药,宣疏化湿以散热配方中可加入泻火解毒、宣疏清化的成分。通利化湿以泄热,根据渗湿于热下之理,使湿热从二便中排泄出来。
Description
技术领域
本发明涉及含有来源于植物组份的疏肝利湿减肥排毒的保健品,特别涉及一种除湿排毒减肥的夏枯草口服液及其制备方法。
背景技术
看中医时,我们常会听医生说“湿热”。那么,什么是湿热,湿热有哪些表现,应注意什么问题呢?要明白湿热,先应了解什么叫湿,什么叫热。所谓湿,即通常所说的水湿,它有外湿和内湿的区分。外湿是由于气候潮湿或涉水淋雨或居室潮湿,使外来水湿入侵人体而引起;内湿是一种病理产物,常与消化功能有关。中医认为脾有“运化水湿”的功能,若体虚消化不良或暴饮暴食,吃过多油腻、甜食,则脾就不能正常运化而使“水湿内停”;且脾虚的人也易招来外湿的入侵,外湿也常因阻脾胃使湿从内生,所以两者是既独立又关联的。所谓热,则是一种热象。而湿热中的热是与湿同时存在的,或因夏秋季节天热湿重,湿与热合并入侵人体,或因湿久留不除而化热,或因“阳热体质”而使湿“从阳化热”,因此,湿与热同时存在是很常见的。湿热体质面部和鼻尖总是油光发亮,易生粉刺、疮疖,常感到口苦、口臭或嘴里有异味,经常大便粘滞不爽,小便有发热感,尿色发黄,女性常带下色黄,男性阴囊总是潮湿多汗。发病倾向:湿热体质的人易患疮疖、黄疸、火热病等征。
湿热的一般表现为:肢体沉重,发热多在午后明显,并不因出汗而减轻;舌苔黄腻,脉数。具体表现因湿热所在不同的部位而有差别:在皮肉则为湿疹或疔疱;在关节筋脉则局部肿痛。但通常所说的湿热多指湿热深入脏腑,特别是脾胃的湿热,可见脘闷腹满,恶心厌食,便溏稀,尿短赤,脉濡数;其它如肝胆湿热表现为肝区胀痛,口苦食欲差,或身目发黄,或发热怕冷交替,脉弦数;膀胱湿热见尿频、尿急,涩少而痛,色黄浊;大肠湿热见腹痛腹泻,甚至里急后重,泻下脓血便,肛门灼热、口渴。
湿热的治疗,一般要分湿重还是热重。湿重的化湿为主,可选用六一散、三仁汤、平胃散;热重以清热为主,可选用连朴饮、茵陈蒿汤、葛根芩连汤。在这一原则下,再根据某些特殊表现选择相应的药,如湿疹、疔疱,加野菊花、地丁草、苦参、白藓皮;关节肿痛加桂枝、忍冬藤、桑枝等;腹泻甚至痢疾加白头翁汤、地榆、车前子等;阴囊湿疹、睾丸胀痛、白带黄臭可加龙胆草、苦参等;血尿可加小蓟草、茅根、石苇、扁蓄等。此外,因热往往依附湿而存在,所以,应注意起居环境的改善和饮食调理,不宜暴饮暴食、酗酒,少吃甜食。
适应能力:湿热体质的人对湿环境或气温偏高,尤其夏末秋初,湿热交蒸气候较难适应。形成原因:1、先天禀赋。2、嗜烟酒的,经常熬夜的。这种人外形不好看,齿黑,舌苔黄腻,满嘴口气,身上味道也大。长期带下色黄,下体异味很大,白带多黄。如果你抽烟喝酒又熬夜,那你注定是个湿热体质。3、滋补不当:如吃很多银耳燕窝冬虫夏草。乌鸡白凤丸等,这样的滋补不当、滋补过度会催生或者加重这种体质。4、长期情绪压抑,借酒浇愁。5、长期生活在湿热环境下,比如广东。亚健康状态特别多见于湿热体质。症状表现:湿热质人的型体特征:形体偏胖或消瘦;常有表现:面垢油光、多有痤疮粉刺、常感口干口苦、眼睛红赤、心烦懈怠、身重困倦、小便赤短、大便燥结或黏滞、男性多有阴囊潮湿、女性常有带下增多。病时上述征象加重;舌象:舌质偏红怠黄腻;脉象:多见滑数;心理特征:性情急躁、容易发怒;适应能力:不能耐受湿热环境。常见的皮肤病:痤疮、湿疹、银屑病、汗疱疹,湿癣、脂溢性皮炎、酒糟鼻等。
调养法则:调体方法:分消湿浊,清泄伏火。调体要点:一,宣疏化湿以散热:中医认为“火郁发之”,就是说体内火邪郁滞,要想办法把火发出来,配方中可加入泻火解毒、宣疏清化的成分。二,通利化湿以泄热,根据渗湿于热下之理,使湿热从二便中排泄出来。在疏肝利湿同时佐以通利之白茅根、淡竹叶、薏苡仁、决明子,使热从下泄。
夏枯草为唇形科植物夏枯草PrunellavulgarisL.的干燥果穗。全国各地均产,主产于江苏、浙江、安徽、河南等地。夏季果穗呈棕红色时采收,除去杂质,晒干。生用。其性辛、苦,寒。归肝、胆经。有清热泻火,明目,散结消肿的功效。
治疗目赤肿痛、头痛眩晕、目珠夜痛。夏枯草苦寒主入肝经,善泻肝火以明目。用治肝火上炎,目赤肿痛,可配桑叶、菊花、决明子等药用。本品清肝明目之中,略兼养肝,配当归、枸杞子,可用于肝阴不足,目珠疼痛,至夜尤甚者;亦可配连翘、甘草用,如夏枯草散(《张氏医通》)。
治疗瘰疬、瘿瘤。本品味辛能散结,苦寒能泄热,常配贝母、连翘等药用以治肝郁化火,痰火凝聚之瘰疬,如夏枯草汤(《外科正宗》);用治瘿瘤,则常配昆布、玄参等用,如夏枯草膏(《医宗金鉴》)。
治疗乳痈肿痛。本品既能清热去肝火,又能散结消肿,可治乳痈肿痛,常与蒲公英同用(《本草汇言》)。若配金银花,可治热毒疮疡,如化毒丹(《青囊秘传》)。
《神农本草经》载其:“主寒热、瘰疬、鼠瘘、头疮,破症。散瘿结气,脚肿湿痹。”《本草纲目》载其:“夏枯草治目疼,用砂糖水浸一夜用,取其能解内热,缓肝火也。楼全善云,夏枯草治目珠疼至夜则甚者,神效,或用苦寒药点之反甚者,亦神效。盖目珠连目本,肝系也,属厥阴之经。夜甚及点苦寒药反甚者,夜与寒亦阴故也。夏枯禀纯阳之气,补厥阴血脉,故治此如神,以阳治阴也。”《重庆堂笔记》子啊起“草,微辛而甘,故散结之中,兼有和阳养阴之功,失血后不寐者服之即寐,其性可见矣。陈久者尤甘,入药为胜。”
药理研究
1.化学成分:本品含三萜皂苷、芸香苷、金丝桃苷等苷类物质及熊果酸、咖啡酸、游离齐敦果酸等有机酸;花穗中含飞燕草素、矢车菊素的花色苷、d-樟脑、d-小茴香酮等。
2.药理作用:本品煎剂、水浸出液、乙醇-水浸出液及乙醇浸出液均可明显降低实验动物血压,茎、叶、穗及全草均有降压作用,但穗的作用较明显;本品水煎醇沉液小鼠腹腔注射,有明显的抗炎作用;本品煎剂在体外对痢疾杆菌、伤寒杆菌、霍乱弧菌、大肠杆菌、变形杆菌、葡萄球菌及人型结核杆菌均有一定的抑制作用。
3.临床研究:结合传统上用于治疗头痛、眩晕,药理研究有降血压作用,现代临床用以治疗高血压病,有助降压;取其散结消肿而常用治甲状腺肿大、淋巴结肿大、乳腺增生、高血压等属于肝热者;用夏枯草、白花蛇舌草、白茅根、甘草、板蓝根、山豆根,水煎服,治疗慢性乙型肝炎50例,治愈33例,好转12例;用夏枯草、白及,共研细末,猪油调膏敷患处,治手足皲裂36例,痊愈34例;用夏枯草100g,水煎2次,泡洗双手,治疗手脱皮证百佘例,均痊愈。
夏枯草配伍当归、白芍夏枯草清肝散淤;当归、白芍养血补血.三者配伍用有解肝郁、养肝血之功效用于治疗肝郁血虚所致诸症.
夏枯草配伍菊花夏枯草清肝火、平肝阳;菊花清热凉肝.二者合用有清肝、凉肝、平肝之功用于治疗肝火上炎、肝经风热引起目赤肿痛;或肝阳上亢导致之头痛、眩晕。
夏枯草配伍昆布、海藻夏枯草清肝火散郁结;昆布、海藻均消痰软坚而利水。三药合用有清火散结、消痰软坚之功效用于治疗肝火痰结所致之瘰疬。
夏枯草配伍玄参、连翘夏枯草清肝火而散郁结;玄参消火散结;连翘解毒散结.三者同用其清火散结之力增强用于治疗痰火互结之瘰疬。
有一类胖子,古人称为“肉人”,我们称为结实型的肥胖,与虚胖相反。他们性格急躁,动不动就发火。其实,这类胖子的急躁易怒并不是天生的,而是因为他们的体内有湿热。湿就是身体内的死水,死水与痰结合,就成了痰湿,死水与热结合,就成了湿热。湿热蕴藏在人体内,排不出去,就会造成胆气上溢,口苦口干,急躁易怒。湿热内阻,阳气被遏,因此人总感觉身重困倦。感觉有一层油似的。除此之外,脸上还经常会长出一些痤疮、粉刺,痤疮很多情况是因为体内湿热郁积,排不出去,最后在脸上激发出来,这也是我们平时说的痘痘。看一个胖子有没有湿热,还应看他的饭量。湿热型的人都食欲旺盛,很能吃,但能吃并不表示脾胃功能正常,相反是处于“胃强脾弱”的病理状态。体内有湿热会影响到胃,胃有湿热,中医称为“胃热湿阻”,胃受热之后,其功能就会亢进,这时人的饭量就会大增,动不动就会感到饥饿。然而,胃纳过旺,就势必加重脾运化的负担,脾有“运化水湿”的作用,脾的负担过重容易造成“水湿内停”。所以,中医又将这类胖子称为“胃热湿阻型肥胖”。分辨湿热型胖子,还要看舌。湿热型胖子舌质偏红舌,苔黄腻,体内的热越盛,舌苔就越黄,就好像煮饭的时候火太大,饭就煮焦了,成了焦黄色的锅巴,如果再不关火,锅巴就会烧成了黑色。所以舌苔的颜色越深,证明你体内的湿热越严重。我们还可以通过观察大小便来判断自己是否有湿热,大便太干燥或者太湿,都是体内湿热的表现。如果身体里热重于湿,则大便燥结;湿重于热,则大便黏滞,小便短赤。湿热体质的人,怕湿怕热,对湿环境或气温偏高,尤其是夏末秋初湿热交蒸气候难以适应。看一个胖子体内是否有湿热,还应看他的眼睛,湿热内蕴,热灼血络,这时人的两眼内就会有红赤的血丝,不痛不痒,西医说这是免疫系统的反应。其实,这就是体内有湿热的表现。总的来说,面垢油光、长痘、舌苔黄腻、脾气急躁、眼睛红赤、大便太干燥或者太湿都是湿热型胖子的表现。
发明内容
本发明所要解决的技术问题在于,本发明针对都市上班族普遍使用电脑办公久视,烟酒无度,夜生活不节制、熬夜、过度用眼总得不到缓解等亚健康行为,针对现代人易生粉刺、疮疖,常感到口苦、口臭或嘴里有异味,经常大便粘滞不爽,小便有发热感,尿色发黄,女性常带下色黄,男性阴囊总是潮湿多汗。湿热蕴藏在人体内,排不出去,就会造成胆气上溢,口苦口干,急躁易怒。湿热内阻,阳气被遏,因此人总感觉身重困倦。本发明选取清火除湿的中药,宣疏化湿以散热排毒减肥。且服用中药比较麻烦,口感不佳,不宜长期服用,效果也不一定理想。中医认为“火郁发之”,就是说体内火邪郁滞,要想办法把火发出来,配方中可加入泻火解毒、宣疏清化的成分。通利化湿以泄热,根据渗湿于热下之理,使湿热从二便中排泄出来。在疏肝利湿同时佐以通利之白茅根、薏仁、决明子等使热从下泄。
为解决上述技术问题,本发明提供一种除湿排毒减肥的夏枯草口服液,其所述夏枯草口服液中包括以下重量份数的原料药:夏枯草10~50份,连翘10~20份,佛手10~20份,冬瓜皮10~20份,板蓝根10~20份,车前子10~20份,陈皮10~20份,薏仁10~20份,芦根10~20份,白茅根10~20份,天花粉10~20份,小米草10~20份,白术10~20份,黄芩10~20份,泽泻10~20份,白花蛇舌草10~20份,淫羊藿10~20份,鸡血藤10~20份,荷叶10~20份。
所述除湿排毒减肥的夏枯草口服液,其所述夏枯草口服液中可以包括以下重量份数的原料药:夏枯草10~30份,连翘10~15份,佛手10~15份,冬瓜皮10~15份,板蓝根10~15份,车前子10~15份,陈皮10~15份,薏仁10~15份,芦根10~15份,白茅根10~15份,天花粉10~20份,小米草10~20份,白术10~20份,黄芩10~20份,泽泻10~20份,白花蛇舌草10~20份,淫羊藿10~20份,鸡血藤10~20份,荷叶10~20份。
所述除湿排毒减肥的夏枯草口服液,其所述夏枯草口服液中还可以包括以下重量份数的原料药:夏枯草10~40份,连翘10~20份,佛手10~20份,冬瓜皮10~20份,板蓝根10~20份,车前子10~20份,陈皮10~20份,薏仁10~20份,芦根10~20份,白茅根10~20份,天花粉10~15份,小米草10~15份,白术10~15份,黄芩10~15份,泽泻10~15份,白花蛇舌草10~15份,淫羊藿10~15份,鸡血藤10~15份,荷叶10~15份。
为解决上述技术问题,本发明还提供一种所述除湿排毒减肥的夏枯草口服液的制备方法,其所述口服液的制备步骤包括:
a.当夏季夏枯草果穗呈棕红色时采收,除去杂质,晒干,生用;
b.将晒干的夏枯草粉碎、浸泡乙醇加热提取;
c.将所述其他原料粉碎、浸泡乙醇提取;
d.将其他原料提取液与制备好的夏枯草提取液混合浓缩,灭菌制备成口服液剂。
所述步骤a中,可以在6-8月间,当夏枯草果穗呈棕红色时,采摘、晾晒,让其干透,备用。
所述步骤b中,可以将夏枯草切碎后置于70-90%乙醇中浸泡1-2小时,在水浴锅内加热到60℃-70℃,浸提2h,每10min搅拌一次,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状滤液,待用。
所述步骤c中,可以将其余原料洗净去杂,放入10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.05的滤液。
所述步骤d中,可以将两种提取液置入双效真空浓缩器中,浓缩至90℃时相对密度为1.25的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,经紫外线消毒杀菌后装瓶。
为解决上述技术问题,本发明也提供一种所述除湿排毒减肥的夏枯草口服液的制备方法,所述夏枯草口服液的制备步骤也包括以下方面:
a.当夏季夏枯草果穗呈棕红色时采收,除去杂质,晒干,生用;
b.将晒干的夏枯草粉碎、浸泡乙醇加热萃取;
c.将所述其他原料粉碎、浸泡乙醇提取;
d.将其他原料提取液与制备好的夏枯草提取液混合浓缩,灭菌制备成口服液剂。
所述步骤b中,夏枯草的萃取步骤进一步为:取备用的夏枯草切碎,泡入5-10倍量的乙醇中,将药粉置有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置。
本发明针对都市上班族普遍使用电脑办公久视,烟酒无度,夜生活不节制、熬夜、过度用眼总得不到缓解等亚健康行为,针对现代人易生粉刺、疮疖,常感到口苦、口臭或嘴里有异味,经常大便粘滞不爽,小便有发热感,尿色发黄,女性常带下色黄,男性阴囊总是潮湿多汗。湿热蕴藏在人体内,排不出去,就会造成胆气上溢,口苦口干,急躁易怒。湿热内阻,阳气被遏,因此人总感觉身重困倦。本发明选取清火除湿的中药,宣疏化湿以散热排毒减肥。通利化湿以泄热,根据渗湿于热下之理,使湿热从二便中排泄出来。在疏肝利湿同时佐以通利之白茅根、淡竹叶、薏苡仁、决明子,使热从下泄。
具体实施方式
有一类胖子,古人称为“肉人”,我们称为结实型的肥胖,与虚胖相反。他们性格急躁,动不动就发火。其实,这类胖子的急躁易怒并不是天生的,而是因为他们的体内有湿热。湿就是身体内的死水,死水与痰结合,就成了痰湿,死水与热结合,就成了湿热。农村的人都知道,麦收以后,农民会将麦秆砌成一垛一垛的,一阵雷雨过后,麦秆被淋湿了,这时你将手伸进麦垛内,就会感觉到里面又潮、又湿、又热,这种湿乎乎、热乎乎的感觉就是湿热。湿热蕴藏在麦垛内,时间一长,麦垛就会腐烂、发酵,农民用它来做肥料;湿热蕴藏在人体内,排不出去,就会造成胆气上溢,口苦口干,急躁易怒。湿热内阻,阳气被遏,因此人总感觉身重困倦。感觉有一层油似的。除此之外,脸上还经常会长出一些痤疮、粉刺,痤疮很多情况是因为体内湿热郁积,排不出去,最后在脸上激发出来,这也是我们平时说的痘痘。看一个胖子有没有湿热,还应看他的饭量。湿热型的人都食欲旺盛,很能吃,但能吃并不表示脾胃功能正常,相反是处于“胃强脾弱”的病理状态。体内有湿热会影响到胃,胃有湿热,中医称为“胃热湿阻”,胃受热之后,其功能就会亢进,这时人的饭量就会大增,动不动就会感到饥饿。然而,胃纳过旺,就势必加重脾运化的负担,脾有“运化水湿”的作用,脾的负担过重容易造成“水湿内停”。所以,中医又将这类胖子称为“胃热湿阻型肥胖”。分辨湿热型胖子,还要看舌。湿热型胖子舌质偏红舌,苔黄腻,体内的热越盛,舌苔就越黄,就好像煮饭的时候火太大,饭就煮焦了,成了焦黄色的锅巴,如果再不关火,锅巴就会烧成了黑色。所以舌苔的颜色越深,证明你体内的湿热越严重。我们还可以通过观察大小便来判断自己是否有湿热,大便太干燥或者太湿,都是体内湿热的表现。如果身体里热重于湿,则大便燥结;湿重于热,则大便黏滞,小便短赤。湿热体质的人,怕湿怕热,对湿环境或气温偏高,尤其是夏末秋初湿热交蒸气候难以适应。看一个胖子体内是否有湿热,还应看他的眼睛,湿热内蕴,热灼血络,这时人的两眼内就会有红赤的血丝,不痛不痒,西医说这是免疫系统的反应。其实,这就是体内有湿热的表现。总的来说,面垢油光、长痘、舌苔黄腻、脾气急躁、眼睛红赤、大便太干燥或者太湿都是湿热型胖子的表现。湿热的治疗,一般要分湿重还是热重。湿重的化湿为主,可选用六一散、三仁汤、平胃散;热重以清热为主,可选用连朴饮、茵陈蒿汤、葛根芩连汤。在这一原则下,再根据某些特殊表现选择相应的药,如湿疹、疔疱,加野菊花、地丁草、苦参、白藓皮;关节肿痛加桂枝、忍冬藤、桑枝等;腹泻甚至痢疾加白头翁汤、地榆、车前子等;阴囊湿疹、睾丸胀痛、白带黄臭可加龙胆草、苦参等;血尿可加小蓟草、茅根、石苇、扁蓄等。此外,因热往往依附湿而存在,所以,应注意起居环境的改善和饮食调理,不宜暴饮暴食、酗酒,少吃甜食。
调养法则:调体方法:分消湿浊,清泄伏火。调体要点:一,宣疏化湿以散热:中医认为“火郁发之”,就是说体内火邪郁滞,要想办法把火发出来,配方中可加入泻火解毒、宣疏清化的成分。二,通利化湿以泄热,根据渗湿于热下之理,使湿热从二便中排泄出来。在疏肝利湿同时佐以通利之白茅根、淡竹叶、薏苡仁、决明子,使热从下泄。
夏枯草全草含有以齐敦果酸(Oleanolicacid)为苷元的三萜皂苷。尚含有芸香苷(Rutin)、金丝桃苷(Hyperoside)等苷类物质.亦含有熊果酸(Ursolicacid)、咖啡酸(Caffeicacid)及游离的齐敦果酸等有机酸.尚含维生素B1、维生素C、维生素K、胡萝卜素、树脂、苦味质、鞣质、挥发油、生物碱及氯化钾等无机盐。
花穗中含飞燕草素(Delphinidin)和矢车菊素(Cyanidin)的花色甙、d-樟脑(d-Camphor)、d-小茴香酮(d-Fenchone)、熊果酸、果穗含熊果酸(ursolicacid),齐墩果酸(oleanolicacid),熊果酸及齐墩果酸为主要甙元的皂甙,胡萝卜甙(daucosterol),β-香树脂醇(β-mayrin)和它的二十四烷酸(tetra-cosanicacid)、二十产烷酸(hexacosanicacid),二十八烷酸(octa-cosanicacid)及三十烷酸(triacontanicacid)的酯。
全草含具抗人免疫缺陷病毒(HIV)的酸性多粮夏枯草多糖(prunellin),还含齐墩果酸,熊果酸,齐墩果酸为甙元的皂甙,芸香甙(rutin),金丝桃甙(hyperoside),咖啡酸(caffeicacid),维生素(vitamins)C、D,D胡萝卜素(carotene),鞣质(tan-nin),和物感(alkaloids)及挥发油,其中含左旋樟脑(camphor),右旋小茴香酮(fenchone)。
现代研究
对心血管系统的作用
夏枯草煎剂(浓度为1∶10万~1∶100万)能使在位兔心和离体蛙心收缩幅度增大,但浓度增大(1∶20~1∶50)则使收缩幅度变小。
夏枯草的水浸出液、乙醇水浸出液和30%乙醇提取物,给麻醉动物腹腔注射、静脉注射或口服均有降低血压作用,静脉注射降压作用比较明显,而口服给药则降压作用微弱.煎剂(100mg/kg)注射于麻醉犬,可产生显著持久的降压作用,但有快速耐受现象,切断迷走神经后,其降压作用明显减弱.对肾性高血压犬,连续服药2周后,血压有中等程度之降低,停药后又恢复至原初水平。夏枯草茎、叶、穗及全草均有降压作用,穗之作用较弱.
抗病原微生物作用体外实验表明:夏枯草煎剂对痢疾杆菌、伤寒杆菌、霍乱弧菌、大肠杆菌、变形杆菌、绿脓杆菌和葡萄球菌、链球菌及人型结核杆菌均有一定抑制作用。
夏枯草可使实验性结核病小鼠的肺部病变有所减轻。夏枯草鲜品榨汁对金黄色葡萄球菌、乙型溶血性链球菌、大肠杆菌、伤寒杆菌、痢疾杆菌、白喉杆菌、炭疽杆菌、绿脓杆菌均有抑制作用。
水浸剂(1∶4)在试管内对许兰黄癣菌、奥杜盎小芽胞黄癣菌等某些常见的致病性皮肤真菌也有不同程度的抑制作用。
免疫抑制作用
实验表明:夏枯草注射液6g(生药)/kg皮下注射,可使豚鼠、小鼠肾上腺明显增大,胸腺、脾脏明显萎缩。夏枯草水煎醇沉液(1∶1)肌肉注射3g(生药)/kg,可使大鼠肾上腺重量增加,而胸腺和脾脏重量减轻,其中胸腺显著萎缩,与对照组相比,平均减轻63.4%。此外,尚能使肾上腺皮质、胸腺及脾脏的组织结构有所改变.
夏枯草煎剂(1∶50~1∶200)可使家兔离体子宫出现强直收缩。对离体兔肠,高浓度能增强其蠕动,以十二指肠最为敏感,回肠敏感性较差。曾有报道,100%夏枯草煎剂能抑制小鼠S180及艾氏腹水癌的生长,但死亡率反较不给药组更高。
夏枯草水煎醇沉液对小鼠巴豆油耳肿胀及大鼠酵母足趾肿胀均有抑制作用。
方中夏枯草、黄芩以疏肝降脂之功;薏仁具有较强的活血化瘀、利水渗湿的作用;白术补脾益气;佛手宽中理气、和胃化痰、消积除痞;夏枯草、黄芩清利解毒,使之清解通利而护肝。诸药配伍,疏利通降而不伤正,益气补中而不壅结,以达到扶正祛邪之目的。对于脂肪肝具有明显的降酶、降脂、抗纤维的作用,使脂肪肝患者有较明显的治疗效果。
车前子味甘,性寒。归肝、肾、肺、小肠经。本品性味甘寒,入肾、膀胱、肝、肺经,功能利水通淋、渗湿止泻、清肝明目、清热化痰,为常用药材。清热利尿通淋,渗湿止泻,明目,祛痰。用于热淋涩痛,水肿胀满,暑湿泄泻,目赤肿痛,痰热咳嗽。车前子种子含多量黏液、车前子酸(Planterolicacid)、车前子甙(Plantaginin)、车前烯醇酸(Plantenolicacid)、琥珀酸(Succinicacid)、腺嘌呤(Adenine或6-Aminopurine)、胆碱(Choline)、梓醇(Catalpol)、蛋白质及各种脂肪酸(棕榈酸、硬脂酸、花生酸、油酸、亚油酸、亚麻酸等),黏液中含酸性黏多糖车前聚糖(Plantasan).尚含维生素A、B1.
茯苓味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。用于脾虚泄泻,带下茯苓既能健脾,又能渗湿,对于脾虚运化失常所致泄泻、带下,应用茯苓有标本兼顾之效,常与党参、白术、山药等配伍。有可用为补肺脾,治气虚之辅佐药。
冬瓜皮,中药名。为葫芦科植物冬瓜Benincasahispida(Thunb.)Cogn.的干燥外层果皮。食用冬瓜时,洗净,削取外层果皮,晒干。归脾、小肠经。利尿消肿。主治用于水肿胀满,小便不利,暑热口渴,小便短赤。《本草纲目》:冬瓜皮(折伤,烧研、酒服)治血滞腰酸痛。[《本草再新》:走皮肤,去湿追风,补脾泻火。
薏仁味甘、淡,性微寒。其中以蕲春四流山村为原产地的最为出名,有健脾利湿、清热排脓、美容养颜功能。薏苡种仁是中国传统的食品资源之一,可做成粥、饭、各种面食供人们食用。尤其对老弱病者更为适宜。薏苡仁:利湿健脾;舒筋除痹;清热排脓。主水肿;脚气;小便淋沥;湿温病;泄泻带下;风湿痹痛;筋脉拘挛;肺痈;肠痈;扁平疣。滇南本草》:清利小便。治热淋疼痛,尿血,止血淋、玉茎疼痛,消水肿。《本草蒙筌》:治肺痈。《纲目》:捣汁和酒服,治黄疸。《草木便方》:能消积聚症瘕,通利二便,行气血。治胸痞满,劳力内伤。
白茅根凉血止血,清热利尿。用于血热吐血,衄血,尿血,热病烦渴,肺热咳嗽,胃热呕吐,湿热黄疸,水肿尿少,热淋涩痛。《本经》:劳伤虚羸,补中益气,除瘀血、血闭寒热,利小便。《别录》:下五淋,除客热在肠胃,止渴坚筋,妇人崩中。久服利人。
天花粉为葫芦科植物栝蒌的根,是一种中药,为清热泻火类药物,其具体功效是清热泻火,生津止渴,排脓消肿。主治:治热病口渴、消渴、黄疸、肺燥咳血、痈肿、痔痿。对于治疗糖尿病,常用它与滋阴药配合使用,以达到标本兼治的作用。《本草汇言》:天花粉,退五脏郁热,如心火盛而舌干口燥,肺火盛而咽肿喉痹,脾火盛而口舌齿肿,痰火盛而咳嗽不宁。若肝火之胁胀走注,肾火之骨蒸烦热,或痈疽已溃未溃,而热毒不散,或五疸身目俱黄,而小水若淋若涩,是皆火热郁结所致,惟此剂能开郁结,降痰火,并能治之。又其性甘寒,善能治渴,从补药而治虚渴,从凉药而治火渴,从气药而治郁渴,从血药而治烦渴,乃治渴之要药也。贯众
佛手根、茎、叶、花、果均可入药,辛、苦、甘、温、无毒;入肝、脾、胃三经,有理气化痰、止呕消胀、舒肝健脾、和胃更多种药用功能。对老年人的气管炎、哮喘病有明显的缓解作用;对一般人的消化不良、胸腹胀闷,有更为显著的疗效。佛手可制成多种中药材,久服有保健益寿的作用。佛手的果实即佛手瓜,是一种葫芦科蔬菜品种。佛手瓜清脆多汁,味美可口,营养价值较高,既可做菜,又能当水果生吃,也是一种健胃、理气的中药。用佛手的叶、花、果泡茶浸酒饮用,有理气健脾、化痰止咳、舒筋活血之功效。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。白术对瘤细胞有细胞毒作用,能降低瘤细胞的增殖率,减低瘤组织的侵袭性,提高机体抗肿瘤反应的能力。白术挥发油对小鼠艾氏腹水癌、淋巴肉瘤腹水型、食管癌(Ecal09)、肉瘤180等有抑制作用。白术内酯B腹腔注射对小鼠肉瘤民。也有显著抑制作用。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
黄芩的根入药,味苦、性寒,有清热燥湿、泻火解毒、止血、安胎等功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床抗菌性比黄连好,而且不产生抗药性。
连翘苦,凉。归经入心、肝、胆经。功能主治清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。《本经》:主寒热,鼠痿,瘰疬,痈肿恶疮,瘿瘤,结热。《别录》:去白虫。《药性论》:主通利五淋,小便不通,除心家客热。《日华子本草》:通小肠,排脓。治疮疖,止痛,通月经。
板蓝根(常用别名:靛青根、蓝靛根、大青根)是一种中药材。其性寒,味先微甜后苦涩,具有清热解毒、预防感冒、利咽之功效。主要用于治疗温毒发斑、舌绛紫暗、烂喉丹痧等疾病。研究表明,板蓝根的根茎提取物通过限制病毒分裂而起到对甲型禽流感病毒,乙型禽流感病毒的抑制杀灭作用,其提取物的水溶液对普通感冒病毒有抑制作用。对流行性乙型脑膜炎病毒有抑制和杀灭作用。菘蓝根对多种细菌也有抑制作用.水浸液对枯草杆菌、金黄色葡萄球菌、八联球菌、大肠杆菌、伤寒杆菌、副伤寒杆菌、痢疾(志贺、弗氏)杆菌、肠炎杆菌等都有不同程度的抑制作用;丙酮浸出液也有类似作用,且对溶血性链球菌有效(皆用琼脂小孔平板法).对A型脑膜炎球菌之抑菌作用与大蒜、金银花相似.对流感病毒PR8株和京科68-1株有明显抑制作用.在试管内板蓝根有杀灭钩端螺旋体的作用.
陈皮理气健脾,调中,燥湿,化痰。主治脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。痰湿壅肺之咳嗽气喘。故陈皮有三大类作用,一是导胸中寒邪,二破滞气,三益脾胃。这三大作用中,主要作用是行脾胃之气。脾胃主运化水湿,故脾胃之气行则能去湿、健脾、化痰,故又可以说,陈皮温能养脾,辛能醒脾,苦能健脾。由于陈皮主行脾胃之气,脾胃地处中焦,中焦之气通行,使三焦之气也随之涌动。三焦为决渎之官,通行水液,与湿相伴;又为藏府之外府,上及心、肺,下及肝、肾。所以陈皮的作用可宽及所有藏府,遍及全身之湿。从肺而言,则辛散肺气,苦泄肺气,温化寒气,能治痰多咳喘,气壅食停;从心而言,则辛开心气,苦泄心火,温化湿浊,能治胸中烦热,口气哕臭;从肝而言,则辛散肝郁,苦降肝火,温化寒湿,所以它能治肝郁有热,饮停食滞;从肾而言,则辛润肾燥,苦泄肾湿,温和肾气,所以它能治命火不足,饮食不化。当然,种种解释都与湿和脾有关,所以它的药性作用发挥余地比较大,一般理气化痰方中均可使用。如李时珍说:“橘皮苦能泄能燥,辛能散能和,其治百病,总是取其理气燥湿之功。同补药则补,同泻药则泻,同升药则升,同降药则降。”如和白术同用,则有补脾胃的作用,与人参、甘草同用则有补肺气的作用,与杏仁同用则有通降大肠气秘的作用,与桃仁同用则有通润大肠血秘的作用,与半夏同用则有燥湿的作用,与茯苓同用则有祛湿的作用,与陈皮同用则有降气止呕的作用,与干姜同用能温化寒痰,与黄连同用能清除热痰或者直接服用胃肠饮治疗胃肠疾病疗效更好。
芦根中药名,用于热病烦渴、胃热呕吐、肺热咳嗽、肺痈吐脓、热淋涩痛。归经:归肺经、胃经。功能:清热生津,除烦,止呕,利尿。主治:用于热病烦渴、胃热呕吐、肺热咳嗽、肺痈吐脓、热淋涩痛。芦根有清热生津、除烦、止呕、利尿的功效,主治热病烦渴、胃热呕吐、肺热咳嗽、肺痈吐脓、热淋涩痛。芦根清中兼透风热,治风热咳嗽可用,常配桑叶、菊花、桔梗等药,以疏风清热,宣肺止咳,方如《温病条辨》桑菊饮。芦根用于热病烦渴。
小米草学名:EuphrasiapectinataTen,为一年生草本植物,全草具药用价值。味苦;性微寒。归膀胱经,功能主治:清热解毒;利尿。主热病口渴;头痛;肺热咳嗽;咽喉肿痛;热淋;小便不利;口疮;痈肿。
泽泻性味:甘,寒。归经:入肾、膀胱经。功效:利水,渗湿,泄热。治小便不利,水肿胀满,呕吐,泻痢,痰饮,脚气,淋病,尿血。《本经》:主风寒湿痹,乳难,消水,养五脏,益气力,肥健。《别录》:补虚损五劳,除五脏痞满,起阴气,止泄精、消渴、淋沥,逐膀胱、三焦停水。《药性论》:主肾虚精自出,治五淋,利膀胱热,直通水道。《日华子本草》:治五劳七伤,主头旋、耳虚鸣,筋骨挛缩,通小肠,止遗沥、尿血。’
白花蛇舌草(学名:Hedyotisdiffusa)为一年生披散草本,高15-50cm。根细长,分枝,白花。茎略带方形或扁圆柱形,光滑无毛,从基部发出多分枝。花期春季。种子棕黄色,细小,且3个棱角。其成药味苦、淡,性寒。主要功效是清热解毒、消痛散结、利尿除湿。尤善治疗各种类型炎症。在临床实践中,发现白花蛇舌草若配伍得当,可治疗多种疾病。主治:肺热喘咳;咽喉肿痛;肠痈;疖肿疮疡;毒蛇咬伤;热淋涩痛;水肿;痢疾;肠炎;湿热黄疸;擅长治疗多种癌肿。
淫羊藿是一种中国常用中药,具有很高的药用价值,滋阴补阳,壮阳强身。味苦涩,适宜失眠者使用。弘景曰:服之使人好为阴阳。西川北部有淫羊,一日百遍合,盖食此藿所致,故名淫羊藿。时珍曰:豆叶曰藿,此叶似之,故亦名藿。淫羊藿、千两金、放杖、刚前,皆言其功力也。鸡筋、黄连祖,皆因其根形也。柳子厚文作仙灵毗,入脐曰毗,此物补下,于理尤通。
鸡血藤味苦微甘、性温,归肝、心、肾经;色赤入血,质润行散;具有活血舒筋,养血调经的功效;主治风湿痹痛,手足麻木,肢体瘫痪,月经不调,经行不畅,痛经,经闭,白细胞减少症。治疗风湿所致的腰膝关节疼痛、风湿痹痛、肢体麻木,常与红花桃仁、赤芍、地龙、黄芪、当归、丹参等配伍。可用于月经不调、经闭、痛经,常与香附、益母草同用。
荷叶食疗作用:荷叶味苦辛微涩、性凉性味寒凉,伤脾胃,务必加少许寒必温缓和寒凉之性。,归心、肝、脾经,清香升散;具有消暑利湿,健脾升阳,散瘀止血的功效。主治暑热烦渴,头痛眩晕,水肿,食少腹胀,泻痢,白带,脱肛,吐血,衄血,咯血,便血,崩漏,产后恶露不净,损伤瘀血。1.清热解暑宜生用,散瘀止血宜炒炭用。新鲜者善清夏季之暑邪,临床常与鲜藿香、鲜佩兰、西瓜翠衣等配伍应用。既能清热解暑,又能升发脾阳,对治疗暑热泄泻有良效,常与扁豆等配伍应用。此外,对脾虚气陷,大便泄泻者,也可加入补脾胃药中同用。
具体实施例1:
6-8月中旬夏枯草果穗呈棕红色时采收,除去杂质,晒干,生用,将其泡入乙醇提取或萃取。
再将其余原料连翘,佛手,冬瓜皮,板蓝根,车前子,陈皮,薏仁,芦根,白茅根,天花粉,小米草,白术,黄芩,泽泻,白花蛇舌草,淫羊藿,鸡血藤,荷叶,粉碎,萃取或提取制成提取液。
两种提取物混合,紫外线杀菌消毒装瓶。
具体实施例2:
6-8月中旬夏枯草果穗呈棕红色时采收,除去杂质,晒干,生用,大概5000g,去杂切碎后将其泡入5-10倍量的乙醇中,将药粉置有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置。
再取其他原料连翘1500g,佛手1500g,冬瓜皮1500g,板蓝根1500g,车前子1500g,陈皮1500g,薏仁1500g,芦根1500g,白茅根1500g,天花粉1500g,小米草1500g,白术1500g,黄芩1500g,泽泻1500g,白花蛇舌草1500g,淫羊藿1500g,鸡血藤1500g,荷叶1500g,洗净晾干,于70℃烘箱中,烘8-12h,取出置于干燥箱内冷却,用粉碎机粉碎过80-100目筛;将过筛的颗粒物浸泡水中12小时,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤,加热浓缩至膏状,静置备用。将膏状提取物置于70-90%乙醇中浸泡1-2小时,在水浴锅内加热到60℃-70℃,浸提2h,每10min搅拌一次,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状滤液。
将上述两种提取液混合置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,紫外线灭菌,包装装瓶。
具体实施例3:
春夏期间都可以采摘夏枯草,将晾晒好的夏枯草4000g浸泡水中12小时,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,成组分1,将所述其余原料连翘1100g,佛手1100g,冬瓜皮1100g,板蓝根1100g,车前子1100g,陈皮1200g,薏仁1100g,芦根1100g,白茅根1100g,天花粉1100g,小米草1100g,白术1100g,黄芩1100g,泽泻1200g,白花蛇舌草1100g,淫羊藿1100g,鸡血藤1100g,荷叶1100g,放入5-10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过,将2次提取液合并静置,减压回收乙醇,并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,作为组分2。将组分1和组分2合并后置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量;浓缩后的膏剂加糊精调和,紫外线消毒杀菌后装瓶。
具体实施例4:
春夏期间都可以采摘夏枯草,将晾晒好的夏枯草3500g切碎,泡入5-10倍量的乙醇中,将药粉置有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置。加热浓缩至膏状,静置备用,成组分1。将所述其余原料连翘1100g,佛手1100g,冬瓜皮1100g,板蓝根1100g,车前子1100g,陈皮1200g,薏仁1100g,芦根1100g,白茅根1100g,天花粉1100g,小米草1100g,白术1100g,黄芩1100g,泽泻1200g,白花蛇舌草1100g,淫羊藿1100g,鸡血藤1100g,荷叶1100g,将所述原料药放入粉碎机粉碎后,将颗粒物放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置,将上述两种提取液合并,作为组分2;合并组分1组分2减压浓缩相对密度为80℃时1.36的滤液,回收乙醇,调入蜂胶,紫外线杀菌后装瓶。
毒理学试验
长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约40平方厘米。洗净脱毛剂,观察24小时后每组豚鼠分别涂本发明茶饮0.2、0.4和0.8ml,分别含生药92、184和368mg,另一组涂溶媒0.8ml每日二次,连续30天,观察豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
2、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用本发明组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。提示,本发明中药茶饮长期使用对局部皮肤及全身重要脏器均未见明显的毒性作用。试验结果表明:本发明中药茶饮实验安全。
累积毒性实验:
本发明中药茶饮对小鼠按7.69、19.18和43.21g生药/kg连续用药15周(1.0ml/100g体重,每天2次)及停药3周后,结果表明:本发明中药茶饮对大鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药15周及停药3周后,大鼠各脏器均无明显改变。说明本发明中药茶饮对大鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
皮肤及体内刺激性试验:
1.取家兔剃毛,用本发明口服液为例,进行诱导和激发接触试验,在24小时和48小时后观察试验家兔,均不见皮肤有红斑及水肿等现象,与阴性对照组无差异。结果表明,该贴剂对皮肤反应强度近于零,即无皮肤变态反应。
2.药物体内灌肠蓄积毒性试验报告
试验方法:选用20只健康小白鼠,雌、雄各10只,剂量设计每5天为一期,每期剂量分别为0.10LD50、0.15LD50、0.22LD50、0.34LD50、0.50LD50,此样品的雌性、雄性小鼠的LD50均为5000m份/k份BW(五个剂量为500、750、1100、1700、2500m份/k份BW)。每5天称体重一次,调整给药量,按0.1ml/10份BW经肛门灌肠。20天后,动物无死亡情况发生,试验结束,按递增剂量给受试物20天后,雌性、雄性动物均无死亡情况发生。
药理实验:
药理学实验:
大黄对正常小鼠由四氯化碳引起的肝损伤有明显保护作用,表现为SGOT显著降低,使肝体比降低(大剂量)。对正常大鼠有显著的利胆作用,胆汁流量增加持续2h。熊去氧胆酸流量增加持续1小时。胆汁中胆固醇、胆红素给药前和给药后组间比较未见显著差异性。为此我们进行了实验研究。
1、材料与方法
药物:本发明提醇沉液的制备:取一定量本发明原料药,水煎两次,水浴上浓缩至一定体积后加95%乙醇沉淀杂质,过液,滤液回收乙醇。配成100%浓度。
对照组为白云山消炎利胆片,国药准字Z44022243。熊去氧胆酸为日本三菱化成生产。
动物ICR小鼠,SD大鼠均由本院动物研究室提供。
1.1对四氯化碳引起的小鼠肝损伤的保护作用:雄性小鼠78只,体重18-23g,按体重随机分层分成六组,每组13只。本发明3个剂量组2.5g/kg、5.0g/kg、10.0g/kg,阳性对照药白云山消炎利胆片10g/kg,模型组,水对照组每天灌胃给药一次,连续6d,于第六天给药后1h除水对照组外其余各组均皮下注射0.15的四氯化碳菜油5ml/kg。16h后摘眼球取血用北京化工厂产的试剂盒测定血清SGPT、SGOT。解剖出肝脏称重,根据处死时体重计算每只小鼠的肝体比、数据以均值士标准差表示,组间进行t检验。
1.2对正常大鼠胆汁流量的影响1.2.1
胆汁流量的测定:取大鼠60只,雄性,体重250~350g,称重随机分成五组,每组12只,实验前禁食12h,不禁水。实验以10%乌拉坦1.0g/kg腹腔注射麻醉,仰位固定于手术台,沿腹正中线切开腹壁,找出十二指肠,在降部肠系膜中找到白色有韧性的胆管,在其下穿二根丝线,结扎乳头部,向肝脏方向作“V”形切口,插入硬质塑料管,结扎固定,即可见有淡黄绿色胆汗流出,试管收集胆汁,术后以盐水纱布覆盖腹腔,待稳定1h后,先收集30min的胆汁,作为给药前的基础值,然后分组给药(经十二指肠)。本发明3个剂量组2.5g/kg、5.0g/kg、10.0g/kg,水对照组,阳性药熊去氧胆酸0.5g/kg。给药后每隔30min收集测量1次胆汁。共4h。
1.2.2胆汁成分的测定:将给药前,给药后4h收集的胆汁测定胆红素(伊利康生物技术有限公司生产,咖啡因法)。胆固醇含量测定用东欧生物工程公司生产的试剂盒,酶法测定。
2实验结果
2.1对四氯化碳引起的小鼠肝损伤的保护作用:四氯化碳引起的SGPT、SGOT显著升高P<0.01,说明造型成功。本发明使SGOT显著降低三个剂量组均P<O.05,本发明对SGPT无明显影响。白云山消炎利胆片使SGPT、SGOT显著降低(P-~O.05)。泽兰10g/kg组使肝体比显著低于四氯化碳模型组。详见表1。
表1本发明对四氯化碳中毒小鼠血清转氨酶的影响(X±S)
注:组间进行t检验,与四氯化碳组比*P<0.05,**P<0.01
2.2对正常大鼠胆汁流量的影响:本发明2.5g/kg组使正常大鼠胆汁流量增加,持续2h,以给药后的30min增加最显著<0.05)。5.0g/kg组给药2h各时相都显著增加<0.05.10.0g/kg组给药后90min内各时相都比对照组显著升高(P<0.01,P<0.05)。阳性药熊去氧胆酸也使流量增加,持续1h。P<0.05详见表2。
表2本发明对麻醉大鼠胆汁流量的影响(X±S)
注t以给药前流量为100%,组问进行t检验,与对照组比*P<0.05,**P<0.01.本发明给药前、给药后涓定胆汁中胆红素和胆同醇含量与对照组相比未见显著差异。详见表3。
表3本发明对大鼠胆汁中胆固醇、胆红素排出量的影响(X±S)
讨论:
本实验表明本发明对CCL4引起的急性肝损伤有明显的保护作用,有使SGOT显著降低作用。血清转氨酶升高主要反映肝细胞变性、坏死,细胞膜通透性升高,使肝细胞内GPT、GOT释放入血所致。有文献报道由CCL4中毒引起的动物SGPT、SGOT升高与肝细胞损伤程度呈粗略平行关系。本发明有选择性地降低SGOT作用,大剂量使肝脏指数减少,也说明本药有较好的保肝作用。
传统医学认为肝胆系的炎症、结石主要是湿热邪毒播体内而致.有人分析100例肝炎病人的肝穿病理结果并结合中医辨证分型得出急性黄疽型肝炎100%属中医湿热的结论.所以清除湿热邪毒用通腑泻下.利湿解毒是常之治则。
临床试验:
自2012年3月至2015年6月,笔者采用自拟清肝利湿降脂汤治疗脂肪肝60例,取得显著疗效,临床资料本组60例中为体检发现者和同行单位的门诊患者,年龄40~50岁,平均44岁;均为男性,疗程1~6年不等。两组资料经Ridit检验,年龄、病程等方面均无显著差异性。具有可比性。诊断依据临床表现和影像学及实验室检查,均符合脂肪肝特征。按就诊顺序随机分为治疗组和对照组各30例。诊断标准:国家中医药管理局中医肝病重点专科写作组主编《中医肝病诊疗常规》2005年10月第1版。
治疗方法
治疗组:本发明口服液,方药组成夏枯草30g,连翘12g,佛手11g冬瓜皮13g,板蓝根12g,车前子11g,陈皮12g,薏仁11g,芦根12g,白茅根11g,天花粉11g,小米草11g,白术12g,黄芩13g,泽泻11g,白花蛇舌草11g,淫羊藿12g,鸡血藤11g,荷叶12g,按实施例方法2制备,每日3瓶,连服2个月后,停服1周,再服1个月为1疗程。
对照组:强肝胶囊(石家庄东方药业有限公司生产)国药准字:ZL0980012,1次5粒,1d3次。两个月1疗程。治疗期间停服任何药物。
疗效标准:临床治愈:症状、体征完全消失,肝功能正常,血脂基本正常,B超提示肝脏声像恢复正常。有效:症状体征消失,谷丙转氨酶及血脂升高部分下降50%以上,B超提示脂肪肝声像图减轻。无效:未达以上标准者。
治疗结果见表1。
表1治疗组与对照组的疗效比较
组别 | 例数 | 痊愈 | 有效 | 无效 | 总有效率* |
治疗组 | 30 | 15 | 13 | 2 | 93% |
对照组 | 30 | 9 | 11 | 10 | 66.67% |
*临床治愈与有效视为有效例数,经统计学处理两组比较有明显差异(P<0.05),治疗组明显优于对照组。
讨论:脂肪肝是近年来才引起医学界高度重视的肝脏脂肪代谢紊乱性疾病。现代医学认为本病主要由脂类摄人过多、肥胖、或毒物(乙醇),或遗传与代谢因素引起过量的脂肪在肝内堆积致病。查阅古典,祖国医学虽没有脂肪肝之病名,但在历代医籍中、有一些类似本病的记载。《灵枢.卫气失常》即已指出人体内有“脂、”有“膏”有“肉”、并根据人体形体的不同而分为“脂人”、“膏人、”“肉人”。其云:“膏者,多气而皮纵缓,故能纵腹垂腴。肉者,身体容大。脂者,其身收小。”张志聪《灵枢集注》云:“中焦之气,蒸津液化.其津微溢于外则皮肉膏肥。佘于肉,则膏脂丰满。”张景岳《类经》亦云:“精液和合而为膏,以填补骨空之中,则为脑为髓,为精为血。”由此可见,上文描述之膏脂与现代医学之脂类物质相类似。同时也说明膏脂实乃人体的生理组成成分之一,属精液之范畴,并可与津液其他成分相互转化,津从浊化为膏,凝则为脂。正常脂膏随血液的运行营养五脏六腑,四肢白骸以及脑髓。若禀赋不足,饮食不节,脾胃失调,情志内伤,肝胆失调,年老体弱,身虚不足等原因,而致摄食过多或传输、利用、排泄异常,皆可是血中脂膏堆积,过多的脂膏浊化。而成为湿浊、痰饮、侵淫隧道,使气血运行障碍,血瘀的本质具体表现在微循环障碍,血流的动力学异常和血液流变学异常。而痰浊与血瘀同是机体脏腑功能失调的病理产物,最终形成肝经痰凝瘀滞,肝内脂肪瘀积的病理变化,而出现“痰证”、“瘀证”、“脉痹”等证。
综合看来当属肝痞、胁痛、症瘕、积聚等范畴基于上述认识,遵循疏肝而降脂、利湿兼化痰、活血而化瘀之大法,采用疏肝降脂、化痰祛湿、活血散结、软坚消积之中药。方中夏枯草、黄芩以疏肝降脂之功;薏仁具有较强的活血化瘀、利水渗湿的作用;白术补脾益气;佛手宽中理气、和胃化痰、消积除痞;夏枯草、黄芩清利解毒,使之清解通利而护肝。诸药配伍,疏利通降而不伤正,益气补中而不壅结,以达到扶正祛邪,清热利湿,排毒减肥之目的。
Claims (10)
1.一种除湿排毒减肥的夏枯草口服液,其特征在于,所述夏枯草口服液中包括以下重量份数的原料药:夏枯草10~50份,连翘10~20份,佛手10~20份,冬瓜皮10~20份,板蓝根10~20份,车前子10~20份,陈皮10~20份,薏仁10~20份,芦根10~20份,白茅根10~20份,天花粉10~20份,小米草10~20份,白术10~20份,黄芩10~20份,泽泻10~20份,白花蛇舌草10~20份,淫羊藿10~20份,鸡血藤10~20份,荷叶10~20份。
2.根据权利要求1所述除湿排毒减肥的夏枯草口服液,其特征在于,所述夏枯草口服液中包括以下重量份数的原料药:夏枯草10~30份,连翘10~15份,佛手10~15份,冬瓜皮10~15份,板蓝根10~15份,车前子10~15份,陈皮10~15份,薏仁10~15份,芦根10~15份,白茅根10~15份,天花粉10~20份,小米草10~20份,白术10~20份,黄芩10~20份,泽泻10~20份,白花蛇舌草10~20份,淫羊藿10~20份,鸡血藤10~20份,荷叶10~20份。
3.根据权利要求1所述除湿排毒减肥的夏枯草口服液,其特征在于,所述夏枯草口服液中包括以下重量份数的原料药:夏枯草10~40份,连翘10~20份,佛手10~20份,冬瓜皮10~20份,板蓝根10~20份,车前子10~20份,陈皮10~20份,薏仁10~20份,芦根10~20份,白茅根10~20份,天花粉10~15份,小米草10~15份,白术10~15份,黄芩10~15份,泽泻10~15份,白花蛇舌草10~15份,淫羊藿10~15份,鸡血藤10~15份,荷叶10~15份。
4.一种如权利要求1~3中任一项所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述口服液的制备步骤包括:
a.当夏季夏枯草果穗呈棕红色时采收,除去杂质,晒干,生用;
b.将晒干的夏枯草粉碎、浸泡乙醇加热提取;
c.将所述其他原料粉碎、浸泡乙醇提取;
d.将其他原料提取液与制备好的夏枯草提取液混合浓缩,灭菌制备成口服液剂。
5.根据权利要求4所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述步骤a中,6-8月间,当夏枯草果穗呈棕红色时,采摘、晾晒,让其干透,备用。
6.根据权利要求4所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述步骤b中,将夏枯草切碎后置于70-90%乙醇中浸泡1-2小时,在水浴锅内加热到60℃-70℃,浸提2h,每10min搅拌一次,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状滤液,待用。
7.根据权利要求4所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述步骤c中,将其余原料洗净去杂,放入10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.05的滤液。
8.根据权利要求4所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述步骤d中,将两种提取液置入双效真空浓缩器中,浓缩至90℃时相对密度为1.25的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,经紫外线消毒杀菌后装瓶。
9.一种如权利要求1~3中任一项所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述夏枯草口服液的制备步骤也包括以下方面:
a.当夏季夏枯草果穗呈棕红色时采收,除去杂质,晒干,生用;
b.将晒干的夏枯草粉碎、浸泡乙醇加热萃取;
c.将所述其他原料粉碎、浸泡乙醇提取;
d.将其他原料提取液与制备好的夏枯草提取液混合浓缩,灭菌制备成口服液剂。
10.根据权利要求9所述除湿排毒减肥的夏枯草口服液的制备方法,其特征在于,所述步骤b中,夏枯草的萃取步骤为:取备用的夏枯草切碎,泡入5-10倍量的乙醇中,将药粉置有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510756003.2A CN105213888A (zh) | 2015-11-09 | 2015-11-09 | 一种除湿排毒减肥的夏枯草口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510756003.2A CN105213888A (zh) | 2015-11-09 | 2015-11-09 | 一种除湿排毒减肥的夏枯草口服液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105213888A true CN105213888A (zh) | 2016-01-06 |
Family
ID=54983400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510756003.2A Pending CN105213888A (zh) | 2015-11-09 | 2015-11-09 | 一种除湿排毒减肥的夏枯草口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105213888A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105795271A (zh) * | 2016-03-30 | 2016-07-27 | 黄山树德堂食品饮料有限公司 | 一种润胃排毒健康饮料及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 抗乙肝制剂 |
CN101264218A (zh) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | 一种清热利湿、疏肝健脾的药物组合及其制备方法 |
CN101391058A (zh) * | 2008-11-05 | 2009-03-25 | 吴伶 | 一种清热解毒制剂 |
CN101468147A (zh) * | 2007-12-25 | 2009-07-01 | 李亮 | 一种减肥降脂的中药制剂 |
CN103736015A (zh) * | 2013-12-30 | 2014-04-23 | 青岛恒波仪器有限公司 | 一种治疗乙型病毒性肝炎的中药制剂及其制备方法 |
-
2015
- 2015-11-09 CN CN201510756003.2A patent/CN105213888A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 抗乙肝制剂 |
CN101468147A (zh) * | 2007-12-25 | 2009-07-01 | 李亮 | 一种减肥降脂的中药制剂 |
CN101264218A (zh) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | 一种清热利湿、疏肝健脾的药物组合及其制备方法 |
CN101391058A (zh) * | 2008-11-05 | 2009-03-25 | 吴伶 | 一种清热解毒制剂 |
CN103736015A (zh) * | 2013-12-30 | 2014-04-23 | 青岛恒波仪器有限公司 | 一种治疗乙型病毒性肝炎的中药制剂及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105795271A (zh) * | 2016-03-30 | 2016-07-27 | 黄山树德堂食品饮料有限公司 | 一种润胃排毒健康饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
CN105343625A (zh) | 一种排毒除湿利胆的蒲公英口服液及其制备方法 | |
CN103417904B (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN101972338A (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN103751709A (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN104472789A (zh) | 一种润肠通便的槐角茶及其制备方法 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN105497816A (zh) | 一种治疗动脉粥样硬化的中药制剂及其制备方法 | |
CN105194421A (zh) | 一种夏枯草降血脂保健口服液及其制备方法 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN104274754A (zh) | 一种治疗小儿遗尿的中药组合物及其制备方法 | |
CN105412697A (zh) | 一种清热除湿、保肝利胆的佩兰口服液及其制备方法 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
CN104286864A (zh) | 一种提高免疫力的沙苑子口服液及其制备方法 | |
CN104324350A (zh) | 一种用于慢性结肠炎的中药组合物及其制备方法 | |
CN105233056A (zh) | 一种清热除湿、利胆排毒的大黄口服液及其制备方法 | |
CN105213888A (zh) | 一种除湿排毒减肥的夏枯草口服液及其制备方法 | |
CN105233052A (zh) | 一种治疗轻度脂肪肝的中药制剂及其制备方法 | |
CN105343516A (zh) | 一种治疗肝火上炎的夏枯草口服液及其制备方法 | |
CN105616984A (zh) | 一种益母草去皱美容膏及其制备方法 | |
CN105169278A (zh) | 一种保肝利胆的蒲公英口服液及其制备方法 | |
CN105343661A (zh) | 一种疏肝利湿的积雪草口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160106 |
|
WD01 | Invention patent application deemed withdrawn after publication |